Suicide Prevention Interventions for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two approaches to prevent suicide among autistic youth. It compares the effectiveness of a customized Safety Planning Intervention tailored for autistic individuals with the same intervention plus additional follow-up support. The aim is to find the best way to reduce short-term suicide risk in autistic individuals. Those who have received a safety plan for autistic youth during a clinical visit might be a good fit. As an unphased trial, participants can contribute to pioneering research that could significantly advance mental health support for autistic youth.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these suicide prevention strategies are safe for autistic individuals?
Research has shown that the Safety Planning Intervention for autistic individuals (SPI-A) is a safety plan specifically adapted for autistic people. This approach reduces the risk of suicide by creating a personalized plan for times of crisis. Tests have demonstrated its effectiveness and acceptability for autistic individuals, yielding promising results.
For the Safety Planning Intervention with structured follow-up contacts (SPI-A+), studies have demonstrated its effectiveness when combined with regular check-ins after the initial plan is made. Although detailed safety data is unavailable, this method relies on proven strategies to ensure safety during high-risk times.
Overall, both approaches in the trial are based on well-researched methods and have been adjusted to better support autistic individuals. While specific safety data for these adaptations is not detailed, their foundation in established methods provides confidence in their safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Safety Planning Interventions tailored for autistic individuals because these approaches are personalized to address the unique needs of autistic youth, which is not typically the focus of standard suicide prevention methods. These interventions are distinct in that they provide an individually tailored safety plan designed specifically for autistic individuals, and the enhanced version includes structured follow-up contacts to ensure ongoing support. This could potentially lead to more effective short-term risk reduction for suicide among autistic youth, a group that often lacks targeted mental health strategies.
What evidence suggests that this trial's treatments could be effective for suicide prevention in autistic individuals?
In this trial, participants will receive either the Safety Planning Intervention for Autistic Individuals (SPI-A) or the Safety Planning Intervention Plus Structured Follow-Up Contacts (SPI-A+). Research has shown that SPI-A is a promising method to reduce suicide risk in autistic youth by creating a personalized plan to help manage suicidal thoughts during difficult times. Studies have found that these tailored plans can effectively lower suicide risk in the short term.
SPI-A+ includes the same personalized planning but adds regular check-ins. These follow-ups strengthen the safety plan and offer extra support. Both methods have shown promise in reducing self-harm and suicide risk among autistic individuals, making them important tools for suicide prevention in this group.13678Who Is on the Research Team?
Danielle Roubinov, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Shari Jager-Hyman, PhD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for young people aged 15-24 with autism who have had suicidal thoughts or behaviors. They must speak English and have received a safety plan tailored for autistic youth during a clinical visit. Those over 18 can consent themselves, while those under need parental consent.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Safety Planning Intervention tailored for Autistic individuals (SPI-A) or SPI-A plus structured follow-up contacts (SPI-A+)
Follow-up
Participants are monitored for changes in suicidal ideation, behavior, and other mental health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Safety Planning Intervention tailored for Autistic Individuals
- Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Seattle Children's Hospital
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
University of Pennsylvania
Collaborator
Nationwide Children's Hospital
Collaborator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborator
Children's Hospital of Philadelphia
Collaborator